Compound Detail
CHEMBL1016
CANDESARTAN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1016 |
| Name | CANDESARTAN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | HTQMVQVXFRQIKW-UHFFFAOYSA-N |
16
Targets
32
Activities
4
Assay Types
30
PK Parameters
20
Publications
6
Known Names
20
Indications
1
Mechanisms
Molecular Properties
440.5
MW (Da)
4.03
ALogP
7
HBA
2
HBD
118.8
PSA (Ų)
0.39
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Type-1 angiotensin II receptor antagonist | ANTAGONIST | Type-1 angiotensin II receptor | ✓ | ✓ |
Indications
Aortic Valve Stenosis Atrial Fibrillation Cardiomyopathy, Dilated Cardiovascular Diseases Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Essential Hypertension Heart Diseases Heart Failure Heart Failure Hypertension Hypertrophy, Left Ventricular Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Cardiomyopathy, Hypertrophic Cocaine-Related Disorders Cognitive Dysfunction Hepatitis C Migraine Disorders Migraine with Aura
ATC Classification
C09CA06
candesartan
Level 1: CARDIOVASCULAR SYSTEM
Level 2: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Activity Summary
IC50 20 meas. best 9.7
Ki 8 meas. best 9.77
Kd 3 meas. best 8.5
EC50 1 meas. best 4.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Ki | 9.77 | 9.77 | 0.2 | 1 |
| Oryctolagus cuniculus CHEMBL374 | IC50 | 9.7 | 9.61 | 0.2 | 2 |
| Type-1 angiotensin II receptor CHEMBL3948 | Ki | 9.19 | 9.19 | 0.6 | 1 |
| Type-1 angiotensin II receptor CHEMBL227 | IC50 | 9.16 | 8.03 | 0.7 | 3 |
| Type-1 angiotensin II receptor A CHEMBL329 | Kd | 8.5 | 8.25 | 3.2 | 2 |
| Type-1 angiotensin II receptor CHEMBL227 | Ki | 8.46 | 8.22 | 3.5 | 2 |
| Unchecked CHEMBL612545 | Kd | 8.02 | 8.02 | 9.6 | 1 |
| Type-1 angiotensin II receptor CHEMBL3948 | IC50 | 7.55 | 7.55 | 28.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.96 | 6.76 | 110.0 | 2 |
| Type-1 angiotensin II receptor CHEMBL3374 | IC50 | 6.96 | 6.96 | 110.0 | 3 |
| Adenosine receptor A3 CHEMBL256 | Ki | 6.16 | 6.16 | 689.5 | 1 |
| Adenosine receptor A3 CHEMBL256 | IC50 | 5.91 | 5.91 | 1219.9 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 5.76 | 5.76 | 1754.4 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 5.52 | 5.52 | 3039.8 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 5.51 | 5.51 | 3065.2 | 1 |
| Thromboxane-A synthase CHEMBL1835 | IC50 | 5.51 | 5.51 | 3059.4 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | Ki | 5.5 | 5.5 | 3200.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.49 | 5.49 | 3276.9 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 5.42 | 5.42 | 3843.0 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | IC50 | 5.37 | 5.37 | 4300.0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 CHEMBL1824 | IC50 | 5.23 | 5.23 | 5947.2 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.05 | 5.05 | 9000.0 | 1 |
| Leukotriene B4 receptor 2 CHEMBL3191 | EC50 | 4.82 | 4.82 | 15000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 3513.1 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3584.4 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3450.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 4125.4 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3586.7 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3452.8 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3632.6 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3258.9 | ng.hr.mL-1 | Homo sapiens |
| AUC | 3814.7 | ng.hr.mL-1 | Homo sapiens |
| CL | 3.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 3.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.667 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.167 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.333 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.333 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 548.74 | nM | Homo sapiens |
| Cmax | 656.59 | nM | Homo sapiens |
| Cmax | 486.31 | nM | Homo sapiens |
| Cmax | 651.59 | nM | Homo sapiens |
| Cmax | 585.3 | nM | Homo sapiens |
| Cmax | 493.57 | nM | Homo sapiens |
| Cmax | 522.64 | nM | Homo sapiens |
| Cmax | 491.08 | nM | Homo sapiens |
| Cmax | 590.52 | nM | Homo sapiens |
| F | 40.0 | % | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 514 |
| - | 10.1101/2024.03.28.586928 | ADMET | 100 |
| 23118328 | 10.1124/dmd.112.046292 | Homo sapiens | 45 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 28666735 | 10.1016/j.bmcl.2017.06.051 | Type-1 angiotensin II receptor | 12 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 7 |
| 8360879 | 10.1021/jm00068a011 | Angiotensin II receptor | 7 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
Data from ChEMBL 36 via Core Engine